Abstract

Paliperidone Tablets Approved for Treatment of Schizophrenia in Adolescents

Paliperidone extended release tablet formulation has recently been approved by the U.S. Food and Drug Administration (FDA) for use in adolescents (aged 12–17 years) with schizophrenia.

• PDF